Sensus Healthcare (SRTS) Cost of Revenue (2016 - 2025)

Sensus Healthcare's Cost of Revenue history runs 10 years deep, the most recent figure standing at $3.0 million for Q4 2025.

• On a quarterly basis, Cost of Revenue fell 48.96% year-over-year to $3.0 million in Q4 2025; TTM through Dec 2025 was $15.6 million, a 10.13% decrease from a year earlier, with the FY2025 full-year figure at $15.6 million, down 10.13% from the prior year.
• Cost of Revenue eased to $3.0 million in Q4 2025 per SRTS's latest filing, from $4.2 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $6.0 million in Q4 2024 and bottomed at $1.5 million in Q1 2021.
• The 5-year median for Cost of Revenue is $3.7 million (2024), against an average of $3.4 million.
• Across the five-year window, Cost of Revenue surged 282.5% in 2021 and sank 50.1% in 2023, its largest moves.
• Year by year, Cost of Revenue stood at $4.2 million in 2021, then grew by 14.03% to $4.8 million in 2022, then decreased by 0.38% to $4.7 million in 2023, then grew by 25.84% to $6.0 million in 2024, then slumped by 48.96% to $3.0 million in 2025.
• Per Business Quant, the three latest SRTS Cost of Revenue figures stand at $3.0 million (Q4 2025), $4.2 million (Q3 2025), and $4.4 million (Q2 2025).